Cat.#: ASSD-225
Description | Antifade Fluorescence Mounting Medium with propidium iodide (aqueous) from Ace Therapeutics is used to prevent the photobleaching of fluorescent proteins and dyes during fluorescent imaging. This product contains propidium iodide which is a widely used red-fluorescent intercalating agent that binds and labels nucleic acids. |
Size | 10 mL |
Applications | Cellular imaging, IHC(IF), ICC |
Mounting | Aqueous (non-setting) |
Antifade | Yes |
Counterstain | Propidium Iodide |
Refractive index | 1.45 |
Emission color | Red |
Excitation | 535 nm |
Emission | 617 nm |
Closest laser lines | 532 nm |
Cell permeable | Yes |
Storage | +4°C or -20°C long-term. |
Shipping | Shipped at 4°C |
Important | If the mounting medium solidifies prematurely during operation, simply heat the bottle to approximately 60°C and the mounting medium will reliquefy. We strongly recommend storing this product away from light. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-212 | 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) | 25 mg | inquiry |
ASSD-145 | Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) | 1 mL | inquiry |
ASSD-104 | Hoechst 33258 (AC104) | 25 mg, 100 mg | inquiry |
ASSD-219 | Tetramethylrhodamine-6-maleimide (AC219) | 5 mg | inquiry |
ASSD-109 | Picro Sirius Red Solution (AC109) | 250 mL | inquiry |
ASSD-228 | ImmunoHistoMount (AC228) | 30 ml | inquiry |
ASSD-159 | Erythrosin B (AC159) | 1g, 5g | inquiry |
ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests | inquiry |
ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.